MADISON MIZENKO: Open Payments
NPI 1558147405 · ESSEX, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$374 in 28 payments from 6 companies in 2025. Trend: 2023 $242 · 2024 $593 · 2025 $374
Food & beverage: $374
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $207 |
| Galderma Laboratories, L.P. | 2 | $42 |
| REVANCE THERAPEUTICS, INC. | 1 | $34 |
| LEO Pharma Inc. | 1 | $33 |
| Lilly USA, LLC | 1 | $33 |
| Incyte Corporation | 1 | $26 |
Products named: SKYRIZI, RINVOQ, NEMLUVIO, DAXXIFY, ANZUPGO, EBGLYSS, OPZELURA.
Industry payments across CT — which companies pay providers there.
